TERRY SMITH: Open Payments
NPI 1477960987 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 22 payments from 10 companies in 2025. Trend: 2023 $392 · 2024 $876 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| ABBVIE INC. | 4 | $93 |
| EMD Serono, Inc. | 3 | $76 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| UCB, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| TG Therapeutics, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
Products named: BREZTRI, QULIPTA, Xeomin, FARXIGA, Rystiggo, FREESTYLE LIBRE 3, Ocrevus Zunovo, UBRELVY.
Industry payments across AZ — which companies pay providers there.
